ChromaDex Corporation Reports Third Quarter 2022 Financial Results

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #earnings--ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the third quarter of 2022. Third Quarter 2022 and Recent Highlights Total net sales were $17.1 million, with $14.6 million from Tru NiagenĀ®, down (1)% each from the prior year quarter. Strong gross margin of 59.8% in the...

Click to view original post